{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T12:37:42Z","timestamp":1768912662762,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009334","name":"Pearl River S and T Nova Program of Guangzhou","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.gene.2019.144262","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T12:37:45Z","timestamp":1574339865000},"page":"144262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["NRAS rs2273267 A&gt;T polymorphism reduces neuroblastoma risk in Chinese children"],"prefix":"10.1016","volume":"727","author":[{"given":"Suhong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenjian","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinghong","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiwen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5907-9436","authenticated-orcid":false,"given":"Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2019.144262_b0005","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/ng.374","article-title":"Common variations in BARD1 influence susceptibility to high-risk neuroblastoma","volume":"41","author":"Capasso","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2019.144262_b0010","doi-asserted-by":"crossref","first-page":"6913","DOI":"10.1158\/0008-5472.CAN-14-0431","article-title":"Common genetic variants in NEFL influence gene expression and neuroblastoma risk","volume":"74","author":"Capasso","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2019.144262_b0015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-1-4419-6033-7_4","article-title":"Genetics and genomics of neuroblastoma","volume":"155","author":"Capasso","year":"2010","journal-title":"Cancer Treat Res."},{"key":"10.1016\/j.gene.2019.144262_b0020","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1111\/jcmm.13226","article-title":"The functional variant rs34330 of CDKN1B is associated with risk of neuroblastoma","volume":"21","author":"Capasso","year":"2017","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.gene.2019.144262_b0025","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1158\/0008-5472.CAN-18-0910","article-title":"A rare missense variant in TCF7L2 associates with colorectal cancer risk by interacting with a GWAS-identified regulatory variant in the MYC enhancer","volume":"78","author":"Chang","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2019.144262_b0030","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41588-018-0045-8","article-title":"Exome-wide analyses identify low-frequency variant in CYP26B1 and additional coding variants associated with esophageal squamous cell carcinoma","volume":"50","author":"Chang","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2019.144262_b0035","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.18632\/aging.101522","article-title":"Relevance of XPD polymorphisms to neuroblastoma risk in Chinese children: a four-center case-control study","volume":"10","author":"Cheng","year":"2018","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.gene.2019.144262_b0040","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrc3526","article-title":"Neuroblastoma: developmental biology, cancer genomics and immunotherapy","volume":"13","author":"Cheung","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.gene.2019.144262_b0045","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1002\/ijc.31822","article-title":"Fine mapping of 2q35 high-risk neuroblastoma locus reveals independent functional risk variants and suggests full-length BARD1 as tumor-suppressor","volume":"143","author":"Cimmino","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.gene.2019.144262_b0050","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1200\/JCO.2008.16.6785","article-title":"The international neuroblastoma risk group (INRG) classification system: an INRG Task Force report","volume":"27","author":"Cohn","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.gene.2019.144262_b0055","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1136\/gut.2005.066514","article-title":"The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma","volume":"54","author":"Conlin","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.gene.2019.144262_b0060","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/aje\/kwh108","article-title":"Maternal medication use and neuroblastoma in offspring","volume":"159","author":"Cook","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.gene.2019.144262_b0065","doi-asserted-by":"crossref","first-page":"8999","DOI":"10.1038\/sj.onc.1207111","article-title":"The dark side of Ras: regulation of apoptosis","volume":"22","author":"Cox","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.gene.2019.144262_b0070","doi-asserted-by":"crossref","first-page":"dju047","DOI":"10.1093\/jnci\/dju047","article-title":"Rare variants in TP53 and susceptibility to neuroblastoma","volume":"106","author":"Diskin","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.gene.2019.144262_b0075","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/ng.2387","article-title":"Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma","volume":"44","author":"Diskin","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2019.144262_b0080","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMoa1305275","article-title":"Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer","volume":"369","author":"Douillard","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.gene.2019.144262_b0085","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00441-017-2773-y","article-title":"Epigenetic regulation of neuroblastoma development","volume":"372","author":"Durinck","year":"2018","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.gene.2019.144262_b0090","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12929-017-0319-y","article-title":"Neuroblastoma treatment in the post-genomic era","volume":"24","author":"Esposito","year":"2017","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.gene.2019.144262_b0095","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.18632\/aging.101855","article-title":"Association of KRAS and NRAS gene polymorphisms with Wilms tumor risk: a four-center case-control study","volume":"11","author":"Fu","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.gene.2019.144262_b0100","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1515\/BC.2005.025","article-title":"Oncogenic Ras in tumour progression and metastasis","volume":"386","author":"Giehl","year":"2005","journal-title":"Biol. Chem."},{"key":"10.1016\/j.gene.2019.144262_b0105","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1111\/jcmm.12836","article-title":"Association of potentially functional variants in the XPG gene with neuroblastoma risk in a Chinese population","volume":"20","author":"He","year":"2016","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.gene.2019.144262_b0110","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S1470-2045(14)70330-4","article-title":"FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial","volume":"15","author":"Heinemann","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.gene.2019.144262_b0115","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1242\/jcs.182873","article-title":"RAS isoforms and mutations in cancer at a glance","volume":"129","author":"Hobbs","year":"2016","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.gene.2019.144262_b0120","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pcl.2014.09.015","article-title":"Neuroblastoma: paradigm for precision medicine","volume":"62","author":"Irwin","year":"2015","journal-title":"Pediatr. Clin. North Am."},{"key":"10.1016\/j.gene.2019.144262_b0125","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1200\/JCO.1991.9.4.581","article-title":"Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study","volume":"9","author":"Look","year":"1991","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.gene.2019.144262_b0130","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrc1097","article-title":"RAS oncogenes: the first 30 years","volume":"3","author":"Malumbres","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.gene.2019.144262_b0135","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMra0804577","article-title":"Recent advances in neuroblastoma","volume":"362","author":"Maris","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.gene.2019.144262_b0140","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(07)60983-0","article-title":"Neuroblastoma","volume":"369","author":"Maris","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.gene.2019.144262_b0145","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1056\/NEJMoa0708698","article-title":"Chromosome 6p22 locus associated with clinically aggressive neuroblastoma","volume":"358","author":"Maris","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.gene.2019.144262_b0150","doi-asserted-by":"crossref","first-page":"16078","DOI":"10.1038\/nrdp.2016.78","article-title":"Neuroblastoma","volume":"2","author":"Matthay","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.gene.2019.144262_b0155","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/aje\/kwh111","article-title":"Day care, childhood infections, and risk of neuroblastoma","volume":"159","author":"Menegaux","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.gene.2019.144262_b0160","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1200\/JCO.2008.16.6876","article-title":"The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report","volume":"27","author":"Monclair","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.gene.2019.144262_b0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002026","article-title":"Phenotype restricted genome-wide association study using a gene-centric approach identifies three low-risk neuroblastoma susceptibility Loci","volume":"7","author":"Nguyen le","year":"2011","journal-title":"PLoS Genet."},{"key":"10.1016\/j.gene.2019.144262_b0170","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1158\/1078-0432.CCR-12-3173","article-title":"Characteristics of lung cancers harboring NRAS mutations","volume":"19","author":"Ohashi","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.gene.2019.144262_b0175","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nature15540","article-title":"Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism","volume":"528","author":"Oldridge","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.gene.2019.144262_b0180","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/15592294.2016.1138195","article-title":"Genome-wide methylation profiling identifies novel methylated genes in neuroblastoma tumors","volume":"11","author":"Olsson","year":"2016","journal-title":"Epigenetics"},{"key":"10.1016\/j.gene.2019.144262_b0185","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1200\/JCO.2016.72.0177","article-title":"Revisions to the international neuroblastoma response criteria: a consensus statement from the national cancer institute clinical trials planning meeting","volume":"35","author":"Park","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.gene.2019.144262_b0190","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.tcb.2004.09.014","article-title":"Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis?","volume":"14","author":"Repasky","year":"2004","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.gene.2019.144262_b0195","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1101\/sqb.2005.70.044","article-title":"Cancer targets in the Ras pathway","volume":"70","author":"Rodriguez-Viciana","year":"2005","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"10.1016\/j.gene.2019.144262_b0200","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/bjc.2012.375","article-title":"Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project","volume":"107","author":"Schleiermacher","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.gene.2019.144262_b0205","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1470-2045(03)01166-5","article-title":"Neuroblastoma: biology and molecular and chromosomal pathology","volume":"4","author":"Schwab","year":"2003","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.gene.2019.144262_b0210","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7","article-title":"The international neuroblastoma pathology classification (the Shimada system)","volume":"86","author":"Shimada","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.gene.2019.144262_b0215","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1073\/pnas.80.8.2112","article-title":"Three human transforming genes are related to the viral ras oncogenes","volume":"80","author":"Shimizu","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.gene.2019.144262_b0220","doi-asserted-by":"crossref","unstructured":"Vauthey, J.N., Zimmitti, G., Kopetz, S.E., Shindoh, J., Chen, S.S., Andreou, A., Curley, S.A., Aloia, T.A. and Maru, D.M., 2013. RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases. Ann. Surg. 258, 619-26; discussion 626-7.","DOI":"10.1097\/SLA.0b013e3182a5025a"},{"key":"10.1016\/j.gene.2019.144262_b0225","doi-asserted-by":"crossref","first-page":"808","DOI":"10.18632\/aging.101429","article-title":"RAN\/RANBP2 polymorphisms and neuroblastoma risk in Chinese children: a three-center case-control study","volume":"10","author":"Wang","year":"2018","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.gene.2019.144262_b0230","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0304-3835(02)00199-4","article-title":"Genetic parameters of neuroblastomas","volume":"184","author":"Westermann","year":"2002","journal-title":"Cancer Lett."},{"key":"10.1016\/j.gene.2019.144262_b0235","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7150\/jca.27482","article-title":"TP53 gene rs1042522 allele G decreases neuroblastoma risk: a two-centre case-control study","volume":"10","author":"Zhang","year":"2019","journal-title":"J. Cancer"},{"key":"10.1016\/j.gene.2019.144262_b0240","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.18632\/aging.101601","article-title":"XRCC1 gene polymorphisms and risk of neuroblastoma in Chinese children","volume":"10","author":"Zhang","year":"2018","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.gene.2019.144262_b0245","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2147\/CMAR.S168515","article-title":"Polymorphisms in MYCN gene and neuroblastoma risk in Chinese children: a 3-center case-control study","volume":"10","author":"Zhou","year":"2018","journal-title":"Cancer Manag. Res."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111919309217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111919309217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T16:27:28Z","timestamp":1759854448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111919309217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":49,"alternative-id":["S0378111919309217"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2019.144262","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NRAS rs2273267 A>T polymorphism reduces neuroblastoma risk in Chinese children","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2019.144262","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"144262"}}